Attaching ECG sensors to the handles of shopping carts could help identify signs of atrial fibrillation in patients who don't even realize they have it. 

The collaboration, announced at ASE 2023, was launched in the name of patient access. 

Diagnosing, treating and managing aortic stenosis is often a challenging task, especially when the patient has a long life expectancy. Shared decision-making can make a significant impact, helping ensure the patient's values and preferences are taken into consideration. 

The FDA Circulatory System Devices Panel is set to review the PMA submissions for the ReCor and Medtronic renal denervation systems to treat patients with uncontrolled hypertension.

Cardiovascular Associates of America, which has already had an eventful 2023, announced a new acquisition that helps expand its footprint in the Sunshine State. 

The 88-year-old patient was originally not seen as a viable candidate for TAVR or surgery.

Cardiologists and other physicians have always believed cardiac transthyretin amyloidosis, a progressive heart condition associated with a high mortality rate, was irreversible. Now, though, new evidence suggests that there may be hope. 

Large language models could have feasibility in the future as clinical support tools that triage patients for imaging services—with additional updates and more training, of course.

"We have been working diligently for months to build ample supply, with doses ready to ship in time for the fall vaccination season in the Northern Hemisphere,” Moderna's CEO said in the announcement.